💨 Abstract

Johnson & Johnson, a leading US healthcare innovator, has announced a $55 billion investment over the next four years in the US for manufacturing, R&D, and technology. This is a 25% increase from the previous four years and will create high-paying jobs, particularly in North Carolina where a new biologics manufacturing facility is being built. The investments aim to develop treatments in areas like oncology, neuroscience, and robotics, and enhance business operations.

Courtesy: theprint.in

Summarized by Einstein Beta 🤖